DGAP-News: Aumann postpones Annual General Meeting due to restrictions caused by the corona virus

Beelen, 19. March 2020

Against the backdrop of the current restrictions caused by the corona virus (SARS-CoV-2), Aumann AG ("Aumann", ISIN: DE000A2DAM03) postpones its 2019 Annual General Meeting initially scheduled to take place on 09 June 2020. Aumann will hold the Annual General Meeting at a later date. The postponement decision will inevitably lead to a corresponding delay of the resolution on the allocation of profit and of the dividend payment.

For Aumann, the health of the company's shareholders as well as of Aumann's employees and our partner companies' employees involved in preparing and facilitating the Annual General Meeting is of highest priority. Aumann is therefore monitoring the development of the corona virus pandemic very closely and follows the risk assessments and guidelines of national and local authorities. Depending on the further development, Aumann will schedule a new date for its 2019 Annual General Meeting. As soon as a new date is fixed, Aumann will release it to the public via www.aumann.com.

About Aumann AG
Aumann is a world-leading manufacturer of innovative speciality machinery and automated production lines with a focus on e-mobility. The company combines unique winding technology for the highly efficient production of electric motors with decades of automation experience, particularly in the automotive industry. Leading companies around the world rely on Aumann solutions for the series production of purely electric and hybrid vehicle drives, and on solutions for production automation.

Further information is available on the Internet via www.aumann.com.

Aumann AG
Dieselstrasse 6
48361 Beelen
Germany
www.aumann.com

The Executive Board
Rolf Beckhoff (CEO)
Sebastian Roll (CFO)

The Supervisory Board
Gert-Maria Freimuth (Chairman)
Christoph Weigler
Dr. Christof Nesemeier 

Court of registration
Münster Local Court, register number: HRB 16399

For further information, please contact
Investor Relations
André Schütz
+49 2586 888 7807
[email protected]